AusBiotech is offering a list of optional activities for Tuesday 23 May. You can opt in for one of the options below during the registration process

 

Medical Technology Research Institute Tour*

10:00am - 4:00pm

The Medical Technology Research Institute Tour will explore some of the world’s leading medical research institutes including the Bionics Institute, the St Vincent's Institute of Medical Research and the newly-developed Aikenhead Centre for Medical Discover (ACMD) research facility, BioFab3D@ACMD. Together these institutes provide a unique model for collaboration between researchers, clinicians, end-users and industry in Melbourne’s CBD.

This tour will provide the opportunity to:

  • Visit cutting-edge institutes and centres
  • View research, facilities and capabilities within Melbourne’s CBD
  • Meet academics driving the latest medical technology research

*The tour is not included in the conference registration. You can register for the tour during the registration process for an additional $15

 

Regulatory affairs and health economics workshop

Deloitte - 550 Bourke Street, Melbourne, VIC 3000

9:30am - 5:30pm

AusMedtech, the national industry group representing the medical devices and diagnostics industry sector in Australia, invites you to attend the Regulatory Affairs and Health Economics Workshop at AusMedtech 2017 & ICMMB 2017.

While Australia boasts a strong market for developing medical technology, yet the landscape is complex and dynamic. This workshop will explore this landscape, presenting current trends and emerging issues that may affect organisations operating in the medical device industry.

The AusMedtech Regulatory Affairs Expert Panel will lead the morning session, focusing on the Therapeutic Goods Administration (TGA)’s Medicines and Medical Devices Review (MMDR), changes in the European Union (EU) and provide an overview of risk classification.

The afternoon session, led by the Health Economics Expert Panel, will discuss prostheses prices and continuing reform of private health insurance. 

View the full program and register here

 

Phillips Ormonde Fitzpatrick networking event

6:00 - 7:30pm

Enjoy a relaxed evening of networking hosted by Phillips Ormonde Fitzpatrick in their Melbourne's offices 

Express your interest, spaces are limited

9:00 - 9:30am

Arrival and registration for AusMedtech 2017 & ICMMB 2017

9:30 - 10:00am 
Official conference welcome

 

Glenn Cross, AusBiotech, CEO

Yosry Morsi, ICMMB Chair

Host state partner welcome
 
             
                            

10:00 - 11:00am

 

Plenary: The Bionic Eye: Restoring sight with vision prostheses

The bionic eye aims to deliver functional vision and improved quality of life for patients with degenerative vision loss caused by conditions such as retinitis pigmentosa and age-related macular degeneration. This talk will present recent developments and the challenges associated with providing clinically safe and commercially competitive technologies to provide functional everyday benefits to patients. The Bionic Vision Australia research program, which has developed a fully implantable device that is based upon the successful prototype study with three patients, will be outlined.

 

Prof Anthony N Burkitt, Director, Bionic Vision Australia, University of Melbourne 

11:00 - 12:00pm

 

 Plenary: We are such stuff as dreams are made on

The concept of harnessing the power of science and technology to deliver personalised medical solutions for trauma, tumour, degeneration, and disease has become an irresistible quest that has galvanised scientists and clinicians. The rapid advances in technology has enabled scientific discovery, greater innovation and more significant impact of treatments.

 

Prof Peter Choong, Sir Hugh Devine Professor of Surgery, University of Melbourne Director of Orthopaedics, St. Vincent’s Hospital Melbourne

12:00 - 1:00pm

Lunch and networking with exhibitors

 

AusMedtech breakout sessions

ICMMB breakout sessions

1:00 - 2:00pm

Emerging technologies

 

Chair: Warren Bingham, VP Asia Pacific, Clinical Genomics

Dr Gil Stynes, Department of Surgery, St. Vincent’s Hospital, University of Melbourne

Jenny O’Neill, CEO and co-founder, Episoft 

Samuel Holt, Founder, Skinview

Regulatory

 

A/Prof John Skerritt, Deputy Secretary, Health Products Regulation Group, Department of Health 

Tissue Engineering, Biomaterials and Biofabrication-Part 1

Keynote speaker: Prof Shengmin Zhang, Huazhong University of Science and Technology

Advances in Stem Cell Therapies – Part 1

Keynote speaker: Prof Samira Musah, Harvard University (USA)

2:00-3:00pm

Business models for medical technologies 

 

Phoebe Macleod, Head of Legal and Licensing, Digital Health, MCRI 

Nick Haan, Executive Director, OncoDx

Medical device clinical trials: Developments in the Australian landscape

 

Chair: Lorraine Chiroiu, Deputy CEO, AusBiotech

 

Measuring the economic value of CTs: MTP Connect's work to support the Indusrty:

Sue MacLeman, CEO & Managing Director, MTPConnect

The new normal: Case study on CTs in non-typical circumstances:

Adele Hosseini, Director of Clinical Affairs, Sirtex

Future Outlook for CTs in Australia:

Dr David Lloyd, Managing Director, Southern Star Research

The evolving nature of CTs for post-market regulation and reimbursement in light of new technologies:

Lyndon Crossley, Director of Clinical affairs, Global Orthopaedic Technology

 

____________________________ 

 

NHMRC National Scientific Committees & their role with clinical trials:

Kylie Sproston, Chief Executive, Bellberry Limited

Tissue Engineering, Biomaterials and Biofabrication-Part 2

 

Keynote speaker: Prof Yasuhiko Tabata, Kyoto University (Japan) 

 Medical, Rehabilitation robotics and Assistive Devices-Part 1

 

Keynote speaker: Prof Romano Zannoli, University of Bologna (Italy) 

 

3:00 - 3:45pm

Afternoon tea and networking with exhibitors

3:45 - 4:45pm

Overcoming barriers to Global market access

Barriers to overcome to access market:

- Regulatory / Clinical trials

- Re-imbursement

- Distribution

- Cultural barriers

 

Chair: Brendan Mason, Managing Director, Sino-Oz 

Frances Pennel-Buck, Inward Investment Specialist - Medical technology sector, UK Department of International Trade

Simon Lewi, Director of Regulatory Affairs, ResMed

Simranjit Singh, General Manager, Medical Devices & Diagnostics Asia, Quintiles

Mike Heyl, Partner, Hogan Lovells

 

 

Is the Company Investable?

IP and Related Issues from Company, Investor and Adviser Perspectives

 

Chair: Rob McInnes, Partner, DibbsBarker

 

Peter Franke, Principal, Franke Hyland

Brigitte Smith, Managing Director, GBS Venture Partners

Dr Abby Bloom, Executive Chair, Acu Rate Pty Ltd 

 

Electrospinning– Part 1

 

Keynote speaker: Prof Xiumei Mo, Donghau University (China)

Neuroscience and Neuroengineering - Part 1

 

Keynote speaker: Prof Rikky Muller, University of California, Berkeley (USA) 

4:45 - 5:45pm

Delivering on the potential of digital health

 

Adam Wardell, Head of Strategy, Innovation and BD&L, Novartis

Dr Rob Grenfell, Health Director, CSIRO Health and Biosecurity

Challenges in re-imbursement of prostheses

 

Chair: Dominic Tilden, Director, Thema Consulting

 

Medical, Rehabilitation robotics and Assistive Devices - Part 2

 

Keynote speaker: Prof Yosry Morsi, Swinburne University of Technology (Australia) 

Bioprinting and Biofabrication - Part 1

7:00 - 7.30pm

Iverson Health Innovations Research Institute Launch Event - Pre-Dinner Drinks

Supported by:

   

 

7:30 - 10:00pm

AusMedtech Cook Conference Dinner

 

 

      

 

7:45 - 8:45am

Australian National Fabrication Facility business breakfast

8:30 - 9:00am

Registration desk opens

9:00 - 9:45am

CEOs' session: What keeps you awake at night

 

Chair: Lusia Guthrie, Chairman, Clever Culture Systems

 

Peter Rowland, Managing Partner, Micro-X Ltd

Michael Kavanagh, CEO and President, Nanosonics

Stuart Elliott, CEO, Planet Innovation

Matthew Hoskin, COO, Sienna Cancer Diagnostics 

ICMMB Plenary

Keynote speaker: Prof William Wagner, University of Pittsburgh (USA)

9:45 - 10:20am

 

BTF panel update on the Biomedical Translation Fund

 

Peter Wills AC, Chair, BTF Committee  

Anne-Marie Birkill, General Partner and Executive Director, OneVentures Pty Ltd 

Dr Chris Nave, Managing Director, Brandon Capital Partners

Dr Amanda Gillon, Investment Manager, BioScience Managers

ICMMB Plenary

Keynote speaker: Professor Eiji Matsuura, Okayama University (Japan)

10:20 - 10:50am

Morning tea

10:50 - 12:00pm

Partnering on Product design and development

 

Biomechanics and Computer modeling/simulation-Part 1

Keynote speaker: Prof Fong-Chin Su, National Cheng Kung University (Taiwan) 

Bioprinting and Biofabrication – Part 2 

12:00-1:00pm

Collaboration for commercialisation

 

Chair: Dr Joanne Boag, Senior Manager, Intellectual Property and Commercialisation, MCRI 

Samih Nabulsi, General Manager, Cook Australia

Charlie Day, CEO, Office of Innovation and Science Australia

What is Goverment's Policy on medtech

 

Chair: Lorraine Chiroiu, Deputy CEO, AusBiotech

Andrew Wear, Director, Medical Technologies and Pharmaceuticals Department of Economic Development, Jobs, Transport and Resources 

Marco Baccanti, Chief Executive, Health Industries South Australia

Biomechanics and Computer modeling/simulation-Part 2

Keynote speaker: Prof Itsu Sen (Yi Qian), Macquarie University (Australia)

Advances in stem cell therapies - Part 2

Keynote speaker: Prof Paul Verma, Monash Institute of Medical Research (Australia)

1:00 - 2:00pm

Lunch

2:00 - 2:45pm

Risk process for Medical deveice Development and Commercialisation

Benefits of following a risk driven process followed by a panel case study

 

ICMMB Plenary

Keynote speaker: Prof Anthony Weiss, University of Sydney (Australia)

2:45 - 3:45pm

Update on the Federal Government Growth Centre

 

Sue MacLeman, Managing Director and CEO, MTPConnect

Michael Grogan, Victorian Director, Advanced Manufacturing Growth Centre 

 

 Advances in medical devices - Design and optimisation

Keynote speaker:

Creating Value in Central Nervous System startups ...  The Backstory

Dr Dan Abrams, Cerebral Therapeutics 

 Electrospinning - Part 2

3:45 - 4:15pm

Afternoon tea

4:15 - 5:15pm

On the couch ICMMB & AusMedtech wrap-up session 

5:15 - 6:15pm

Closing Drinks

supported by: